168 related articles for article (PubMed ID: 27827891)
1. Factors Affecting the Baseline and Post-Treatment Scores on the Hopkins Verbal Learning Test-Revised Japanese Version before and after Whole-Brain Radiation Therapy.
Saito H; Tanaka K; Kanemoto A; Nakano T; Abe E; Aoyama H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827891
[TBL] [Abstract][Full Text] [Related]
2. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
3. CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.
Caine C; Deshmukh S; Gondi V; Mehta M; Tomé W; Corn BW; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Raben A; Shi W; Wendland M; Kachnic L
J Neurooncol; 2016 Jan; 126(2):327-36. PubMed ID: 26511494
[TBL] [Abstract][Full Text] [Related]
4. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study.
Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC
Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802
[TBL] [Abstract][Full Text] [Related]
6. The value of 4-month neurocognitive function as an endpoint in brain metastases trials.
Onodera S; Aoyama H; Tha KK; Hashimoto N; Toyomaki A; Terae S; Shirato H
J Neurooncol; 2014 Nov; 120(2):311-9. PubMed ID: 25037611
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
Yang WC; Chen YF; Yang CC; Wu PF; Chan HM; Chen JL; Chen GY; Cheng JC; Kuo SH; Hsu FM
Neuro Oncol; 2021 Mar; 23(3):478-486. PubMed ID: 32789503
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
[TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.
Ma TM; Grimm J; McIntyre R; Anderson-Keightly H; Kleinberg LR; Hales RK; Moore J; Vannorsdall T; Redmond KJ
Radiother Oncol; 2017 Nov; 125(2):234-240. PubMed ID: 29128167
[TBL] [Abstract][Full Text] [Related]
10. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
[TBL] [Abstract][Full Text] [Related]
11. Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study.
Pospisil P; Kazda T; Hynkova L; Bulik M; Dobiaskova M; Burkon P; Laack NN; Slampa P; Jancalek R
Radiother Oncol; 2017 Mar; 122(3):373-379. PubMed ID: 28063694
[TBL] [Abstract][Full Text] [Related]
12. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
Li J; Bentzen SM; Renschler M; Mehta MP
J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015
[TBL] [Abstract][Full Text] [Related]
13. Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933.
Abraham CD; Pugh SL; Bovi JA; Gondi V; Mehta MP; Benzinger T; Owen CJ; Lo SS; Kundapur V; Brown PD; Sun AY; Howard SP; DeNittis AS; Robinson CG; Kachnic LA
Adv Radiat Oncol; 2022; 7(6):100859. PubMed ID: 36420209
[TBL] [Abstract][Full Text] [Related]
14. Memory function before and after whole brain radiotherapy in patients with and without brain metastases.
Welzel G; Fleckenstein K; Schaefer J; Hermann B; Kraus-Tiefenbacher U; Mai SK; Wenz F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1311-8. PubMed ID: 18448270
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933.
Bovi JA; Pugh SL; Sabsevitz D; Robinson CG; Paulson E; Mehta MP; Gondi V; Kundapur V; Shahin MS; Chao ST; Machtay M; DeNittis AS; Laack NN; Greenspoon JN; Moore KN; Huang J; Dominello MM; Kachnic LA
Adv Radiat Oncol; 2019; 4(4):579-586. PubMed ID: 31673651
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal proton MR spectroscopy as a novel approach in the assessment of radiation injury and the correlation to neurocognitive function impairment: initial experiences.
Pospisil P; Kazda T; Bulik M; Dobiaskova M; Burkon P; Hynkova L; Slampa P; Jancalek R
Radiat Oncol; 2015 Oct; 10():211. PubMed ID: 26474857
[TBL] [Abstract][Full Text] [Related]
17. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
18. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
Li J; Bentzen SM; Li J; Renschler M; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
[TBL] [Abstract][Full Text] [Related]
20. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]